Results 11 to 20 of about 30,834 (256)

Anticancer Activity of Measles-Mumps-Rubella MMR Vaccine Viruses against Glioblastoma. [PDF]

Cancers (Basel), 2023
Khalid Z, Coco S, Ullah N, Pulliero A, Cortese K, Varesano S, Orsi A, Izzotti A.   +7 more
europepmc   +3 more sources

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine [PDF]

Human Vaccines & Immunotherapeutics
Measles, mumps, and rubella (MMR) are highly infectious viral diseases affecting young children and have high secondary attack rates. Present MMR vaccines show consistent seroconversion rates for anti-measles and anti-rubella antibodies with variable ...
Nitin Shah, Apurba Ghosh, Kishore Kumar, Trayambak Dutta, Manish Mahajan   +4 more
doaj   +2 more sources

MMR vaccine: the continuing saga

BMJ, 2001
The current low uptake of measles, mumps, and rubella (MMR) vaccine in some parts of the United Kingdom has led to well publicised concerns about the potential for measles outbreaks among primary school entrants. This has coincided with prepublication publicity last week of a paper casting doubts on the adequacy of the evidence which secured the ...
D, Elliman, H, Bedford
openaire   +5 more sources

Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity. [PDF]

J Med Virol
Anichini G, Terrosi C, Alessandri G, Miceli GB, Borrelli E, Fabrizi S, Savellini GG, Cusi MG.   +7 more
europepmc   +3 more sources

Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak. [PDF]

JAMA Netw Open
Goodwin Cartwright BM, Masters NB, Gilbert KM, Rodriguez PJ, Do D, Stucky N.   +5 more
europepmc   +2 more sources

Comparison of Effectiveness and Safety of Immunotherapy of Warts with Intralesional Versus Subcutaneous MMR Vaccine: An Open Label Randomized, Parallel Group, Clinical Trial.

Indian J Dermatol, 2022
Saha A, Bahalia I, Agarwal S, Banerjee A, Bandyopadhyay D.   +4 more
europepmc   +2 more sources

Comparative Efficacy and Safety of Intralesional MMR Vaccine and Vitamin D3 in Managing Nongenital Warts: A Systematic Review and Meta-Analysis. [PDF]

J Cosmet Dermatol
Balach R, Khalid A, Rasool A, Kashif A, Ahmad A, Zafar A, Ibrahim M, Javed AS, Hasan M, Ahmed S.   +9 more
europepmc   +2 more sources

MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection. [PDF]

mBio, 2021
Marakasova E, Baranova A.
europepmc   +2 more sources

Measles, mumps, rubella (MMR) vaccine [PDF]

Ceylon Medical Journal, 2011
SP Lamabadusuriya
openaire   +4 more sources

Complete Regression of Anogenital Warts Following Intralesional Measles-Mumps-Rubella (MMR) Vaccine: A Case of Two. [PDF]

Clin Cosmet Investig Dermatol
Achdiat PA, Dwigunasari PR, Suwarsa O, Tsaqilah L, Maharani RH.   +4 more
europepmc   +3 more sources